Evidence map›Paper›PMID 32607687›Full record

ArticleVirchows Archiv : an international journal of pathology2020

A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer.

Inger-Heidi Bjerkli, Elin Hadler-Olsen, Elisabeth Sivy Nginamau, Helene Laurvik, Tine M Søland, Daniela Elena Costea, Lars Uhlin-Hansen, Sonja E Steigen

Open access · hybridAbstract read
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Inger-Heidi BjerkliDepartment of Otorhinolaryngology, University Hospital of North Norway, Tromsø, Norway.
Elin Hadler-OlsenDepartment of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.
Elisabeth Sivy NginamauDepartment of Pathology, Haukeland University Hospital, Bergen, Norway.
Helene LaurvikDepartment of Pathology, Rikshospitalet, Oslo University Hospital, Oslo, Norway.
Tine M SølandDepartment of Pathology, Rikshospitalet, Oslo University Hospital, Oslo, Norway.
Daniela Elena CosteaDepartment of Pathology, Haukeland University Hospital, Bergen, Norway.
Lars Uhlin-HansenDepartment of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.
Sonja E SteigenDepartment of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway. Sonja.eriksson.steigen@uit.no.ORCID http://orcid.org/0000-0001-8376-2489
University Hospital of North Norway · NOHaukeland University Hospital · NOOslo University Hospital · NONorthern Norway Regional Health Authority · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We wanted to evaluate the prognostic value of common histopathological variables in a large cohort of patients with cancer in the mobile tongue as such information can be important for treatment stratification of the individual patient, especially for patients with low-stage disease. In addition, we wanted to investigate whether an alternative scoring model with fewer options would compromise the prognostic value. One hundred fifty patients with oral tongue squamous cell carcinomas that were treated in curative intent and with available HE-stained tumor sections were included. We reclassified all tumors and performed univariate and multivariate survival analyses of histopathological and clinical variables. For the complete cohort, lymph node status, grade of differentiation, perineural infiltration, and lymphocytic infiltration were independent prognosticators. In the low-stage disease group, independent prognostic factors were tumor size, grade of differentiation, and lymphocytic infiltrate. For patients with low-stage disease, a histo-score combining the scores for tumor differentiation and lymphocytic infiltrate identified a group of patients with particularly low survival, as patients with moderately or poorly differentiated tumors and little lymphocytic infiltrate had a less favorable 5-year survival outcome than patients in the high-stage disease group. This study shows that a histo-score combining tumor differentiation and lymphocytic infiltration should be given special consideration in treatment planning. Our results also illustrate that many variables can be scored with fewer options than previously suggested to increase their reproducibility, and still maintain their prognostic value.

Indexed as

AdultAgedAged, 80 and overCell DifferentiationFemaleHumansLymphocytes, Tumor-InfiltratingMaleMiddle AgedPrognosisSquamous Cell Carcinoma of Head and NeckTongue NeoplasmsDifferentiationHisto-scoreLow-stageLymphocyte infiltrateOral squamous cell carcinomaPrognostic factors

Identifiers

PMID32607687
PMCPMC7683438
OpenAlexW3039635008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.